Last edition
News about "Amacathera"
AmacaThera, a leading biotechnology company specialising in next-generation hydrogel-based drug delivery systems, has entered into an exclusive global licensing agreement with Pacira BioSciences, Inc., a leader in non-opioid pain management, to develop and commercialise AMT-143.
AmacaThera | 05/11/2025 | By Darshana
AmacaThera, Global Pharma Giant Team Up to Create Advanced Long-Acting Biologic Using AmacaGel
Through this partnership, a single-injection, long-acting biologic will be developed using AmacaThera's advanced hydrogel delivery platform, AmacaGel™, in combination with the partner's therapeutic. <br />
Amacathera | 09/04/2025 | By Abha | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy